Skip to main content
Log in

Quantitative simultaneous 99mTc-ECD/123I-FP-CIT SPECT in Parkinson’s disease and multiple system atrophy

  • Short Communication
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to investigate the feasibility and utility of dual-isotope SPECT for differential diagnosis of idiopathic Parkinson’s disease (IPD) and multiple system atrophy (MSA).

Methods

Simultaneous 99mTc-ECD/123I-FP-CIT studies were performed in nine normal controls, five IPD patients, and five MSA patients. Projections were corrected for scatter, cross-talk, and high-energy penetration, and iteratively reconstructed while correcting for patient-specific attenuation and variable collimator response. Perfusion and dopamine transporter (DAT) function were assessed using voxel-based statistical parametric mapping (SPM2) and volume of interest quantitation. DAT binding potential (BP) and asymmetry index (AI) were estimated in the putamen and caudate nucleus.

Results

Striatal BP was lower in IPD (55%) and MSA (23%) compared to normal controls (p<0.01) , and in IPD compared to MSA (p<0.05). AI was greater for IPD than for MSA and controls in both the caudate nucleus and the putamen (p<0.05). There was significantly decreased perfusion in the left and right nucleus lentiformis in MSA compared to IPD and controls (p<0.05).

Conclusion

Dual-isotope studies are both feasible in and promising for the diagnosis of parkinsonian syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. El Fakhri G, Maksud P, Kijewski MF, Habert MO, Todd-Pokropek A, Aurengo A, et al. Scatter and cross-talk corrections in simultaneous Tc-99m/I-123 brain SPECT using constrained factor analysis and artificial neural networks. IEEE Trans Nucl Sci 2000;47:1573–80

    Article  Google Scholar 

  2. El Fakhri G, Moore SC, Maksud P, Aurengo A, Kijewski MF. Absolute activity quantitation in simultaneous I-123/Tc-99m brain SPECT. J Nucl Med 2001;42:300–8

    PubMed  Google Scholar 

  3. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:1009–13

    PubMed  Google Scholar 

  4. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94–8

    Article  PubMed  Google Scholar 

  5. Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith C, Frackowiak R. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995;2:189–210

    Article  Google Scholar 

  6. Cointepas Y, Mangin JF, Garnero L, Poline JB, Benali H. BrainVISA: software platform for visualization and analysis of multi-modality brain data. Neuroimage 2001;13:S98

    Article  Google Scholar 

  7. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89

    Article  PubMed  Google Scholar 

  8. Swanson RL, Newberg AB, Acton PD, Siderowf A, Wintering N, Alavi A, et al. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson’s disease. Eur J Nucl Med Mol Imaging 2004;32:302–7

    Article  PubMed  Google Scholar 

  9. Thobois S, Jahanshahi M, Pinto S, Frackowiak R, Limousin-Dowseya P. PET and SPECT functional imaging studies in parkinsonian syndromes: from the lesion to its consequences. NeuroImage 2004;23:1–16

    Article  PubMed  Google Scholar 

  10. Bosman T, Van Laere K, Santens P. Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson’s disease. Eur J Nucl Med 2003;30:16–24

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported in part by grants from the French Ministry of Health: FUSPARK project (Réseau National Technologie Santé), Partners Collaborative Research (grant 137561), and the National Institutes of Health (grants RO1-EB000802 and RO1-EB001989).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Georges El Fakhri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

El Fakhri, G., Habert, MO., Maksud, P. et al. Quantitative simultaneous 99mTc-ECD/123I-FP-CIT SPECT in Parkinson’s disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 33, 87–92 (2006). https://doi.org/10.1007/s00259-005-1920-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-005-1920-y

Keywords

Navigation